Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Retatrutide in Thailand — Triple Agonist GLP-1/GIP/Glucagon
Recommended by Doctor
Investigational Peptide · Research Use

Retatrutide in Thailand — Triple Agonist GLP-1/GIP/Glucagon

Healthi Life · Ekkamai 10, Bangkok

Retatrutide is an investigational triple agonist of GLP-1, GIP and glucagon receptors (Eli Lilly, Phase III TRIUMPH program). At Healthi Life in Thailand it is offered exclusively for medical research and under strict physician supervision, with biomarker monitoring and documented informed consent.

Starting from

Per vial (includes consultation & biomarker review)

Physician-Supervised
Biomarker-Monitored
Contraindication Review
Ekkamai, Bangkok

What You Get

Physician consultation with research-use informed consent
Extended baseline and monthly biomarker review
Injection guidance and adverse-event monitoring
Why Choose This Treatment

How Retatrutide Is Studied

Triple Agonist Mechanism

Retatrutide targets GLP-1, GIP and glucagon receptors simultaneously, an investigational metabolic pathway.

Physician-Supervised

Used strictly under physician oversight at Healthi Life Ekkamai with documented informed consent.

Biomarker-Monitored

Extended baseline labs and monthly follow-up frame every titration decision.

Contraindication Review

Personal and family history screening before initiation, with explicit exclusion criteria.

Subcutaneous Administration

Weekly subcutaneous injection with in-clinic guidance and adverse-event monitoring.

Research Framework

Offered exclusively for medical research and structured longevity programs, never as cosmetic use.

Is This Right For You?

Ideal For

  • Adults with documented medical eligibility and informed consent
  • Guests committed to extended baseline biomarkers and monthly follow-up
  • Candidates integrated into a physician-led longevity or metabolic program

Not Recommended For

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • Active pancreatitis or severe gastrointestinal disease
  • Severe hepatic or renal impairment without specialist clearance
Your Journey

Our 4-Step Retatrutide Program

1

Medical Intake & Consent

Full history, contraindication screening and signed research-use informed consent.

2

Extended Baseline

HbA1c, lipid panel, glucagon, hepatic and renal function established before initiation.

3

Titration

Progressive dose escalation under physician supervision based on tolerability and response.

4

Monthly Follow-Up

Clinical review, adverse-event monitoring and biomarker reassessment every four weeks.

Medical Excellence

Why Trust Healthi Life

Physician-led protocols, international certifications, and a commitment to guest safety in Bangkok.

ISO 9001:2015 Certified
GMP Compliant Laboratory
Thai Medical Council Registered
International Guest Safety Standards
Packages

Choose Your Program

RECOMMENDED

Retatrutide — 1 vial

฿10,000

  • 1 vial (research use)
  • Physician consultation
  • Baseline biomarker review
  • Injection guidance & adverse-event monitoring
FAQ

Frequently Asked Questions

Medically reviewed by Dr. Petch & Dr. First

ABLM Certified · IBLM Diplomate · MSc Dermatology, Thammasat University

Last reviewed: April 9, 2026

Book a Retatrutide Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, informed consent and an extended baseline biomarker plan.

Location

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

Hours

Mon-Sat: 11:00 AM – 7:00 PM

Response time: Under 2 hours